Mesa Laboratories Inc
NASDAQ:MLAB
Mesa Laboratories Inc
Revenue
Mesa Laboratories Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Mesa Laboratories Inc
NASDAQ:MLAB
|
Revenue
$212.9m
|
CAGR 3-Years
18%
|
CAGR 5-Years
15%
|
CAGR 10-Years
16%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$20.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
Mesa Laboratories Inc
Revenue Breakdown
Breakdown by Geography
Mesa Laboratories Inc
Total Revenue:
219.1m
USD
|
United States:
117.3m
USD
|
Other:
76m
USD
|
China:
25.8m
USD
|
Breakdown by Segments
Mesa Laboratories Inc
Total Revenue:
219.1m
USD
|
Product:
180.5m
USD
|
Service:
38.6m
USD
|
See Also
What is Mesa Laboratories Inc's Revenue?
Revenue
212.9m
USD
Based on the financial report for Dec 31, 2023, Mesa Laboratories Inc's Revenue amounts to 212.9m USD.
What is Mesa Laboratories Inc's Revenue growth rate?
Revenue CAGR 10Y
16%
Over the last year, the Revenue growth was -4%. The average annual Revenue growth rates for Mesa Laboratories Inc have been 18% over the past three years , 15% over the past five years , and 16% over the past ten years .